Neoadjuvant radiotherapy and anastomosis dehiscence after total mesorectal excision for stage II and III rectal cancer  by Szynglarewicz, Bartłomiej et al.
Neoadjuvant radiotherapy and anastomosis dehiscence 
after total mesorectal excision for stage II and III 
rectal cancer
Bartłomiej Szynglarewicz2BDEF, Rafał Matkowski2,5BDF, Adam Maciejczyk3BD, 
Piotr Kasprzak4BE, Daniel Sydor6C, Józef Forgacz2BG, Marek Pudełko2AG, 
Zygmunt Grzebieniak1AD
1  2nd Chair and Department of General Surgery and Surgical Oncology, Medical University in Wrocław, 
Wrocław, Poland
2 2nd Department of Surgical Oncology, Lower Silesian Oncology Centre, Wrocław, Poland
3 Department of Radiotherapy, Lower Silesian Oncology Centre, Wrocław, Poland
4 Division of Radiology, Lower Silesian Oncology Centre, Wrocław, Poland
5 Chair of Oncology, Medical University in Wrocław, Wrocław, Poland
6 Department of Mathematics and Informatics, University of Wrocław, Wrocław, Poland
Source of support: Department sources.
Summary
 Background Anterior resection is nowadays the preferred option of surgical treatment for rec-
tal cancer without sphincter involvement. However, this operation is associated 
with the risk of anastomosis dehiscence (AD).
 Aim The aim of this study was to estimate the inﬂ uence of neoadjuvant radiothera-
py and other factors on the risk of anastomosis dehiscence after total mesorectal 
excision for stage II and III rectal cancer.
 Materials/Methods One hundred and thirty consecutive patients operated on due to histologically 
conﬁ rmed rectal carcinoma were studied with prospective data collection. Elective 
surgery with curative intent was administered. All patients underwent sphincter-
sparing anterior resection with total mesorectal excision. End-to-end anastomosis 
with double stapled technique was performed. Impact of patient-, tumour- and 
treatment-related variables on anastomosis dehiscence rate was evaluated in uni-
variate and multivariate analysis.
Results  Incidence of AD was 10.6%. There was no leakage-related mortality. Univariate 
analysis showed that patient’s age and gender, presence of lymph node metastas-
es and irradiation setting (pre- vs post-operative) did not signiﬁ cantly inﬂ uence 
dehiscence rate (P>0.05). Tumour level at or below 7cm from the anal verge was 
related to increased AD risk with statistical importance (P=0.0438). Neither pelvic 
drainage nor omentoplasty effectively protected the anastomosis. Proximal diver-
sion with protective stoma resulted in signiﬁ cantly decreasing AD risk (P=0.0012). 
In multivariate analysis the presence of transversostomy was found as the most im-
portant factor independently associated with signiﬁ cantly lower incidence of AD.
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BACKGROUND
In the year 1990 combined postoperative chemo-
radiation as adjuvant treatment for rectal cancer 
was recommended by the National Institute of 
Health [1]. At the end of the last century results 
of the Swedish Rectal Cancer Trial suggested on-
cological beneﬁ ts of preoperative short-term hy-
pofractionated high-dose irradiation [2]. These 
advantages were thereafter conﬁ rmed in other 
prospective studies [3,4] and randomised mul-
ticentre trials [5,6]. Neoadjuvant radiotherapy 
25Gy in ﬁ ve daily fractions of 5Gy can decrease 
local recurrence risk by 50–70%, enhance long-
term survival by 10%, and increase resectability 
and sphincter preservation rates [7]. Because of 
the short treatment time, early operation, rela-
tively low cost and patient comfort this radiation 
schedule became a widely adopted procedure. 
However, in experimental studies in animal mod-
els performed in the eighties anastomotic de-
hiscence (AD) rates of up to 80% were noticed 
when preoperative radiation was given [8–11]. 
The clinical impact of neoadjuvant radiothera-
py on the risk of anastomotic dehiscence in rec-
tal cancer patients is still unclear and remains a 
matter of debate.
AIM
The aim of the study was to evaluate the inci-
dence of clinically symptomatic AD following 
anterior resection with TME with and without 
preoperative radiotherapy for stage II and III 
rectal cancer and to estimate the association 
of AD rate with patient-, tumour- and treat-
ment-related variables in uni- and multivari-
ate analysis.
MATERIAL AND METHODS
Patients
From 01.2000 to 12.2003 at the Second 
Department of Surgical Oncology of the Lower 
Silesian Oncology Centre, 130 patients with rec-
tal adenocarcinoma underwent anterior resec-
tion fulﬁ lling the selection criteria: tumour sit-
ed maximum 12cm from the anal verge, absence 
of distant metastases, absence of macroscopic in-
ﬁ ltration of adjacent organs, distal and radial R0 
margins, lack of intra-operative bowel perfora-
tion, total integrity of doughnuts after retrieval 
of the stapler, complete integrity of the anasto-
mosis during intra-operative testing. Ninety-four 
of them at UICC stages II and III received radi-
ation and chemotherapy and entered the study. 
The stage was established with preoperative en-
dorectal ultrasound (tumour direct penetration 
beyond the bowel wall without enlarged lymph 
nodes was considered stage II, presence of en-
larged lymph nodes at the mesorectum suggest-
ing tumour involvement was regarded as stage 
III) and conﬁ rmed by histological examination 
of the resected specimen. For patients in stage I 
adjuvant therapy was not administered and they 
were treated with surgery alone. Therefore, they 
were not enrolled for the study. Patients under-
went pre-operative bowel preparation with 4L 
polyethylene glycol solution and administration 
of prophylactic antibiotics.
Surgical procedures
Vessel ligation before intestine preparation was 
done. Resection was performed according to 
TME technique, with sharp dissection under the 
 Conclusions Neoadjuvant radiotherapy does not seem to be a signiﬁ cant risk factor for anas-
tomosis dehiscence, even after resection of low-sited tumours, but proximal di-
version with temporary stoma needs to be considered.
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direct vision of the avascular plane between pari-
etal and visceral pelvic fascia. Special effort was 
made for adequate colon mobilisation. End-to-
end anastomosis with double-stapling technique 
was constructed. The rectum was transected with 
the transverse stapler Proximate TLH 30 (Ethicon 
Endo Surgery Europe, Norderstedt, Germany). 
Circular intraluminal stapler Proximate ILS 
(Ethicon Endo Surgery Europe, Norderstedt, 
Germany) was introduced transanally and ﬁ red 
with the guidance of the abdominal surgeon. 
Intestine wash-out was made by povidone iodine. 
Anastomosis integrity was examined by transanal 
air insufﬂ ation of the bowel immersed in saline 
solution.
Radiation and chemotherapy
Radiotherapy was delivered by linear accelerator 
(6–18MV). All patients received whole pelvic ra-
diation by three ﬁ elds (two laterals and one pos-
terior). The lateral ﬁ elds covered the sacrum and 
coccyx posteriorly and the femoral head anteri-
orly. The dose was prescribed to the 95% isod-
ose line. Wedges of different degrees were em-
ployed over the lateral ﬁ elds to homogenize the 
isodose distribution. The isodose distribution 
was designed by 2D treatment planning system. 
Forty-nine patients received preoperative ﬁ ve-
day scheduled high-dose hypofractionated radi-
ation with a total dose of 25Gy in daily fractions 
of 5Gy. The upper limit of all the pelvic ﬁ elds was 
at the L5-S1 level and the lower one was 5cm be-
low the tumour. Radiotherapy was followed by sur-
gery within 7 days and postoperative chemother-
apy with 5-ﬂ uorouracil (325mg/m2) and folinic 
acid (20mg/m2) in six ﬁ ve-day courses with two-
hour bolus injection. Forty-ﬁ ve patients received 
combined postoperative radiochemotherapy. For 
them radiation was delivered in traditional 25 dai-
ly fractions of 1.8Gy over ﬁ ve weeks to the total 
dose of 45Gy followed by a boost to the primary 
tumour site with 2cm margins of up to 50.4Gy. 
Chemotherapy with 5-ﬂ uorouracil (325mg/m2) 
and folinic acid (20mg/m2) by intravenous bo-
lus injection was given also in six ﬁ ve-day courses. 
The two ﬁ rst courses were administered before 
radiation, the third and fourth were performed 
concomitantly in the ﬁ rst and ﬁ fth week of radi-
otherapy, respectively, and the last two courses 
were given after radiation.
Dehiscence diagnosis
AD was considered to be present if any of the fol-
lowing features were noticed: presence of peri-
tonitis caused by anastomotic dehiscence, pres-
ence of feculent substances and gas from the 
pelvic drain, or presence of pelvic abscess with 
the demonstration of leakage by transrectal ex-
amination, endoscopy, contrast enema, endorec-
tal ultrasound or CT scanning.
Risk factors and protection methods
Apart from neoadjuvant radiotherapy, gender 
(female n=46, male n=48), age (range 33–89 
years; mean x=60.6±10.3, median M=61; ≤60 years 
n=53, >60 years n=41), stage (II n=59, III n=35) 
and tumour distance from the anal verge (P≤7 
cm n=38, >7 cm n=56) were regarded as factors 
with a possible impact on the AD risk. Operative 
procedures potentially protecting the anasto-
mosis involved: defunctioning transversostomy 
(n=62, lack n=32), wrapping the anastomosis 
with omentum (n=26, lack n=68) and pelvic no-
suction drainage (n=55, lack n=56).
Statistical analysis
All data were prospectively collected. Statistical 
analysis was performed with the computer pro-
gram set EPIINFO Ver. 3.2. All data were entered 
into the computer database. Univariate analysis 
was performed with Pearson’s chi-square test with 
Yates’ correction. Odds Ratio (OR) and Relative 
Risk (RR) with 95% conﬁ dence intervals (95% 
CI) were calculated. For multivariate analysis the 
logistic regression model (quasi-Newton estima-
tion) was used. P value <0.05 was considered sta-
tistically signiﬁ cant.
RESULTS
There was no post-operative or dehiscence-relat-
ed death. Symptomatic AD was noticed in 10 cas-
es, giving a rate of 10.6%. AD developed in 12% 
of patients (n=6 of 49) preoperatively irradiated 
and 9% of patients (n=4 of 45) without neoadju-
vant radiotherapy. The difference was not signif-
icant (P=0.5981; OD=1.430, 95%CI 0.376–5.438; 
RR=1.378, 95%CI 0.415–4.568). Five patients with 
preoperative radiation and AD (83%) had low-
sited tumour. None of them had protective sto-
ma. All irradiated patients with proximal diver-
sion independently of tumour level were free of 
symptomatic AD.
Among patients who developed AD, 6 were ef-
fectively treated conservatively (total parenter-
al nutrition, antibiotics, abscess drainage with 
the guidance of radiology). The other 4 patients 
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underwent relaparotomy: 3 of them required a di-
version stoma with anastomosis preservation, one 
developed total dehiscence of the anastomosis 
and required Hartmann’s procedure. Preferred 
time of stoma closure was 12 weeks after prima-
ry operation. Bowel reconstruction following 
Hartmann’s resection was successful.
AD rate was higher in patients older than 60 years, 
in females and in stage III tumours but without 
statistical signiﬁ cance. The only clinical parame-
ter signiﬁ cantly related to enhanced AD risk was 
tumour localisation at 7cm or below from the 
anal verge (P=0.0438; OD=3.989, 95%CI 0.961–
16.558; RR=3.439, 95%CI 0.948–12.470).
From surgical procedures neither pelvic drainage 
nor omentoplasty signiﬁ cantly inﬂ uenced AD risk. 
In contrast, the presence of protective stoma was 
associated with lower AD rate and effectively pro-
tected patients from symptomatic AD with statis-
tical importance (P=0.0012; OD=10.000, 95%CI 
1.979–50.542; RR=7.750, 95%CI 1.747–34.375).
In multivariate analysis the most important statis-
tically signiﬁ cant factor that independently inﬂ u-
enced lower risk of AD was the presence of prox-
imal diversion with temporary stoma (P=0.00735; 
OD=10.186, 95%CI 2.017–59.743; RR=8.073, 
95%CI 1.845–37.914).
Data are shown in Table 1.
DISCUSSION
In our study the only signiﬁ cant clinical parame-
ter was the localisation level of rectal malignan-
cy. Increased AD risk after resection of low-sited 
tumours (below 5–7cm from the anal verge) was 
often observed and seems to be well document-
ed [12–14]. We found that proximal diversion by 
temporary stoma signiﬁ cantly decreased the risk 
of symptomatic AD. Similarly, in recent papers 
[12,15], but not in all of them [13], its effective-
ness for anastomosis protection was emphasised. 
The results of a large multi-centre German trial 
conﬁ rmed that defunctioning stoma can reduce 
the AD risk and decrease the rate of AD requir-
ing surgery due to severe consequences of leak-
age [16]. Thus, in spite of the high cost, risk of 
stoma-related complications and low acceptance 
by patients the use of proximal diversion seems to 
be valid in cases with low anastomoses, especially 
when other AD risk factors are present.
In our series AD did not occur signiﬁ cantly more 
often after neoadjuvant radiotherapy. In con-
trast, other authors noticed enhanced AD rates 
when preoperative radiation was given [17–19]. 
Vermeulen et al. reported that compared with sur-
gery alone, preoperative short-term radiotherapy 
Risk factor Option n AD P OR 95% CI RR 95% CI
Patient’s gender MaleFemale
48
46
10%
11% 0.9432 0.953 0.257–3.539 0.958 0.297–3.093
Patient’s age >60≤60
41
53
12%
9% 0.6668 1.333 0.359–4.955 1.293 0.401–4.168
UICC stage IIIII
59
35
10%
11% 0.8482 0.877 0.230–3.353 0.890 0.270–2.937
Radiation therapy PreopPostop
49
45
12%
9% 0.5981 1.430 0.376–5.438 1.378 0.415–4.568
Tumor level ≤7cm>7cm
38
56
18%
5% 0.0438 3.989 0.961–16.558 3.439 0.948–12.470
Defunctioning stoma AbsentPresent
32
62
25%
3% 0.0012 10.000 1.979–50.542 7.750 1.747–34.375
Pelvic drainage AbsentPresent
29
65
10%
11% 0.9509 0.956 0.229–3.993 0.961 0.267–3.454
Omental wrapping AbsentPresent
68
26
10%
12% 0.8611 0.880 0.209–3.695 0.892 0.249–3.192
Table 1. Risk factors for anastomosis dehiscence.
n – number of patients; AD – rate of anastomosis dehiscence; P – signifi cance level; OR – Odds ratio; RR – relative risk; 95% CI – 95% 
confi dence interval; Preop – preoperative; Postop – postoperative.
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signiﬁ cantly increased the number of AD (41% 
vs 4%, p=0.006) whether or not protective stoma 
was performed [20]. Analysis of a random sample 
from all rectal cancer patients in Sweden operat-
ed on from 1987 to 1995 showed that short-term 
radiation was an independent AD risk factor [13]. 
High-dose preoperative radiotherapy impairs leu-
kocyte production, increases postoperative infec-
tive complication rate and signiﬁ cantly reduces 
collagen concentration in infected patients [21]. 
On the other hand, similarly to us, investigations 
of the Dutch Colorectal Cancer Study Group 
did not reveal a signiﬁ cant impact of neoadju-
vant radiation on AD rate [22,23]. The results 
of a Polish randomized trial suggest that 5×5 Gy 
radiotherapy is not less effective than long-term 
radiation for sphincter preservation [24]. Bujko 
et al. observed that short-course irradiation was 
not associated with enhanced risk of postoper-
ative morbidity [25] and radiation toxicity [26] 
when compared to conventionally fractionated 
radiochemotherapy.
The ﬁ ndings of recent experimental studies are 
also discrepant. Milsom et al. noticed more fre-
quent AD in animals irradiated before surgery to 
a total dose of 42.5Gy (29% vs 8%, p<0.05) [27]. 
Preoperative radiation resulted in enhanced gross 
and microscopic inﬂ ammatory scores [27], re-
duced perianastomotic blood ﬂ ow [27,28], sig-
niﬁ cantly decreased local collagen concentra-
tion and hydroxyproline content [29]. In other 
series anastomosis healing was not compromised 
by preoperative radiation [30,31]. Some suggest 
that radiotherapy does not inﬂ uence the anasto-
mosis outcome but may delay the normal heal-
ing process [32,33]. In clinical practice only the 
distal limb of the anastomosis consists of irradi-
ated bowel (rectal remnant) while the proximal 
limb is not irradiated (colon). De Meerleer et al. 
reported that compared to non-irradiated bowel 
the anastomosis strength of unilaterally radiated 
colorectal anastomosis was not altered but in the 
case of bilaterally irradiated bowel it was signiﬁ -
cantly reduced and dose-dependent [34]. Other 
authors also observed that preoperative radiation 
of 25–80Gy did not affect the clinical, mechan-
ical, histological and biochemical features re-
ﬂ ecting anastomosis healing: pelvic abscess and 
peritonitis rate, bursting pressure, epithelial re-
generation, collagen concentration and hydrox-
yproline content, respectively [35–38].
For optimal combined-modality treatment plan-
ning, risk-beneﬁ t analysis should be considered. 
It has to be remembered that hypofractionated 
radiotherapy may increase the incidence of uro-
genital complications, faecal incontinence and 
other bowel dysfunction. Because of radiation-
related complications and side effects the mon-
olithic approach to apply the same schedule of 
radiotherapy for all patients with stage II and III 
rectal cancer is questioned by some [39]. Further 
studies are needed for more accurate identiﬁ ca-
tion of patients requiring adjuvant therapy.
CONCLUSIONS
1. Neoadjuvant radiotherapy does not seem to in-
ﬂ uence the anastomosis dehiscence rate after 
total mesorectal excision for rectal carcinoma.
2. Risk of dehiscence is signiﬁ cantly related to low 
site of the primary tumour.
3. Effective anastomosis protection can be achieved 
using proximal diversion with defunctioning 
temporary stoma.
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